Morita Naomi, Yasumori Toshio, Nakayama Kazuo
Biomedicine, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan.
Biochem Pharmacol. 2003 Jun 1;65(11):1843-52. doi: 10.1016/s0006-2952(03)00178-3.
The two most frequently observed single nucleotide polymorphisms (SNPs) of the human multidrug resistance 1 (MDR1) gene are 2677G/T/A (893Ala/Ser/Thr) and 3435C/T (no amino acid substitution). In this study, six forms of MDR1 cDNAs with the SNPs were expressed in LLC-PK1 cells and their transport activities were determined. Nearly identical amounts of the recombinant MDR1 proteins were expressed in the established cell lines using the Flp recombinase, which integrates a gene of interest at a specific genomic location. Four structurally diverse compounds: verapamil, digoxin, vinblastine and cyclosporin A, were examined for transcellular transport activities and intracellular accumulation. No significant differences were observed between cells expressing five polymorphic types of the MDR1 cDNAs (2677G/3435T, 2677A/3435C, 2677A/3435T, 2677T/3435C, 2677T/3435T) and cells expressing the wild-type (2677G/3435C). These results suggested that the two frequently observed MDR1 SNPs had no effect on the transport activities of MDR1 proteins expressed in LLC-PK1 cells in vitro, and other genetic or environmental factors might control the expression of MDR1 and the in vivo activity of MDR1.
人类多药耐药1(MDR1)基因中最常观察到的两个单核苷酸多态性(SNP)是2677G/T/A(893位丙氨酸/丝氨酸/苏氨酸)和3435C/T(无氨基酸替换)。在本研究中,六种带有这些SNP的MDR1 cDNA形式在LLC-PK1细胞中表达,并测定了它们的转运活性。使用Flp重组酶在已建立的细胞系中表达了几乎等量的重组MDR1蛋白,该酶可将感兴趣的基因整合到特定的基因组位置。研究了四种结构不同的化合物:维拉帕米、地高辛、长春碱和环孢素A的跨细胞转运活性和细胞内蓄积情况。表达五种多态型MDR1 cDNA(2677G/3435T、2677A/3435C、2677A/3435T、2677T/3435C、2677T/3435T)的细胞与表达野生型(2677G/34- 35C)的细胞之间未观察到显著差异。这些结果表明,这两个常观察到的MDR1 SNP对体外LLC-PK1细胞中表达的MDR1蛋白的转运活性没有影响,其他遗传或环境因素可能控制MDR1的表达及MDR1在体内的活性。